Benzinga · Oct 9, 2026
Stifel Maintains Buy on Align Technology, Lowers Price Target to $175
Stifel analyst Jonathan Block maintains Align Technology (NASDAQ:ALGN) with a Buy and lowers the price target from $210 to $175.
AL
NASDAQ · ALGN
Align Technology, Inc.
Healthcare · Medical - Devices
$143.54
Up+$0.94 (+0.65%)
Updated Oct 14, 2026, 7:59 PM
SID Score
5.4/10
Composite research score
Smart Money
60/100
Neutral
- Market cap
- 13.64B
- P/E ratio
- 33.21
- Dividend yield
- 0.00%
- 52-week range
- $138.05 – $200.44
- Volume
- 997.88K
- Avg. volume
- 1.19M
Price performance · ALGN
ALGN price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 13, 2026
ALGN closed at $143.54 after 21 trading sessions, down 2.35% for the selected period.
- Last close
- $143.54
- Period change
- -2.35%
- Period low
- $139.87
- Period high
- $153.29
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 13, 2026 | $141.01 | $143.65 | $139.81 | $143.54 | 997.88K |
| Oct 12, 2026 | $143.23 | $144.11 | $140.33 | $140.42 | 849.89K |
| Oct 9, 2026 | $141.00 | $142.86 | $140.10 | $142.71 | 1.08M |
| Oct 8, 2026 | $138.59 | $141.115 | $138.05 | $141.03 | 1.34M |
| Oct 7, 2026 | $140.46 | $141.00 | $138.9501 | $139.87 | 678.98K |
| Oct 6, 2026 | $141.96 | $143.64 | $141.135 | $141.45 | 1.02M |
| Oct 5, 2026 | $140.07 | $142.35 | $138.36 | $140.65 | 1.68M |
| Oct 2, 2026 | $147.09 | $147.09 | $143.23 | $143.74 | 550K |
| Oct 1, 2026 | $145.00 | $146.23 | $143.23 | $145.345 | 619.79K |
| Sep 30, 2026 | $144.61 | $146.68 | $142.8286 | $145.35 | 917.82K |
| Sep 29, 2026 | $145.00 | $145.93 | $142.24 | $144.01 | 937.28K |
| Sep 28, 2026 | $145.00 | $146.20 | $143.325 | $145.00 | 886.5K |
| Sep 25, 2026 | $145.57 | $148.165 | $144.20 | $146.78 | 829.61K |
| Sep 24, 2026 | $148.65 | $149.22 | $145.27 | $145.625 | 785.81K |
| Sep 23, 2026 | $152.50 | $153.40 | $147.07 | $148.17 | 1.33M |
| Sep 22, 2026 | $149.17 | $154.10 | $147.615 | $153.29 | 967K |
| Sep 21, 2026 | $147.97 | $148.37 | $145.55 | $146.88 | 975.82K |
| Sep 18, 2026 | $149.52 | $150.78 | $146.20 | $147.61 | 1.5M |
| Sep 17, 2026 | $151.21 | $152.105 | $148.98 | $149.71 | 796.01K |
| Sep 16, 2026 | $148.18 | $152.46 | $147.56 | $150.45 | 946.51K |
| Sep 15, 2026 | $151.46 | $152.49 | $146.82 | $147.00 | 1.03M |
Latest ALGN news
The latest Smart Investors Daily articles mentioning ALGN.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ALGN research
Overview
Company profile and research snapshot.
Company profile
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $169.88
- Implied upside
- —
- Analysts
- 23
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 9, 2026 | Stifel | Buy | — |
| Oct 5, 2026 | Evercore ISI Group | In-Line | — |
| Jul 9, 2026 | BMO Capital | Outperform | — |
| Apr 30, 2026 | Evercore ISI Group | Outperform | — |
| Apr 24, 2026 | Morgan Stanley | Equal-Weight | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 7, 2026
3 Reasons ALGN is Risky and 1 Stock to Buy Instead
Over the past six months, Align Technology’s shares (currently trading at $144.11) have posted a disappointing 13.6% loss, well below the S&P 500’s 17.5% gain. This may have investors wondering how to approach the situation.
Yahoo · Oct 5, 2026
Align Technology Shares Fall After Evercore ISI Downgrades Stock
Align Technology (NASDAQ:ALGN) shares fell 1. 7% in pre-market trading after Evercore ISI downgraded the medical device company to In Line from Outperform.
Benzinga · Oct 5, 2026
Evercore ISI Group Downgrades Align Technology to In-Line, Lowers Price Target to $155
Evercore ISI Group analyst Elizabeth Anderson downgrades Align Technology (NASDAQ:ALGN) from Outperform to In-Line and lowers the price target from $220 to $155.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
